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Summary
Limb-girdle muscular dystrophy (LGMD) is a clinically and genetically heterogeneous group of disorders,
with both recessive and dominant forms reported. Recently, a series of recessive LGMD families were linked
to chromosome 1 5q. We report herein the results of our linkage studies in a previously reported large autosomal
dominant family. The LGMD gene in this family was localized to chromosome 5q22.3-31.3 by using a
series of CA(n) microsatellite repeat markers. Linkage to 15q was excluded. These findings confirm genetic
heterogeneity in this clinically diverse syndrome.
Introduction
Limb-girdle muscular dystrophy (LGMD) is a progres-
sive muscular dystrophy with weakness beginning in
the hip and shoulder girdle and later progressing to the
distal muscles. The LGMD diagnostic classification
is ill-defined and heterogeneous (Morton and Chung
1959; Brooke 1986). The diagnosis is clouded by tre-
mendous variability in expression, as well as by
asymptomatic obligate heterozygotes in autosomal
dominant families (DeCoster et al. 1974). The diagno-
sis is further complicated in that other neurogenic/
myopathic disorders, particularly Becker muscular
dystrophy (BMD) and Kugelberg-Welander syndrome
(Kazakov et al. 1977; Coers et al. 1979), may clini-
cally mimic LGMD. Fascioscapulohumeral muscular
dystrophy (FSHMD) should also be included in the
differential diagnosis ofLGMD (Chyatte et al. 1966).
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Initial reports ofLGMD described families with re-
cessive inheritance (LGM2; MIM 253600) (Jackson
and Strehler 1968; Shokeir and Kobrinsky 1976) and
sporadic cases (Morton and Chung 1959). Later re-
ports described families with dominant forms (LGM1;
MIM 159000) (Chutkow et al. 1986; Gilchrist et al.
1988). Thus, there is clearly heterogeneity in the mode
of genetic transmission in LGMD. Clinical heteroge-
neity is also present, as evidenced both by the variation
in age at onset and rate of progression and, to a lesser
extent, by the distribution of muscle weakness. Clini-
cal heterogeneity is present both within the dominant
class and between the dominant and recessive classes.
Recently, Beckmann et al. (1991) reported linkage
of a series of recessive (LGM2) families, collected from
the Isle of La Reunion, to the anonymous marker
D1SS2S (pTHH114), with a maximum LOD score
(Z) of 5.52 at recombination fraction (0) = 0. Studies
by Young et al. (1991) have subsequently supported
this localization in a large, highly inbred Amish family
(Jackson and Strehler 1968). Linkage studies reported
by Gilchrist et al. (1988) and Speer et al. (1989) failed
to find linkage in this form of LGMD. We report, in
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this family, evidence for linkage to chromosome 5q
and exclusion of linkage to chromosome 15q.
Subjects and Methods
Family 39: Ascertainment and Diagnostic Criteria
This large LGM1 family (fig. 1) was ascertained
through the Duke University Medical Center Neuro-
muscular Research and Muscular Dystrophy Associa-
tion Clinic. A detailed clinical description of the family
has been reported elsewhere (Gilchrist et al. 1988).
The family has been substantially expanded since the
original report. Blood from 218 individuals was ob-
tained for creatine kinase testing, DNA extraction,
and lymphoblastoid cell line establishment.
The diagnostic criteria for LGM1 were proximal leg
weakness with or without proximal arm weakness,
absent ankle deep-tendon reflexes, and elevated cre-
atine kinase values or creatine kinase MB fractions.
Obligate heterozygotes were classified as affected, in
the linkage analysis. Individuals with normal exami-
nations and with creatine kinase levels within normal
limits were assigned heterozygosity risks based on
their age at examination. The probability of carrying
the LGM1 gene was generated from a normal distribu-
tion by assuming that the mean age at onset in this
family was 27.1 years (a = 8.5 years). Family mem-
bers who had signs or symptoms suggestive of LGM1
but who did not meet the strictly defined diagnostic
criteria were considered to be of unknown disease sta-
tus. All spouses were considered normal with respect
to clinical status. This study includes genotype results
on 218 individuals, 49 ofwhom were affected, 103 of
whom had normal examination, 28 of whom were
considered of unknown disease status for this evalua-
tion, and 38 of whom were unrelated spouses.
Genotype Analysis
DNA was isolated from leukocytes or from trans-
formed cell lines. After digestion with restriction en-
zymes, the DNA was transferred to Gene Screen Plus
(NEN) and hybridized in 50O formamide according
to methods described elsewhere (Yamaoka et al.
1990). Polymorphic DNA markers were obtained
from the American Type Culture Collection or from
the investigators who developed them. Paternity and
sample integrity were confirmed with the anonymous
probe D2S44 (pYNH24) (Nakamura et al. 1987).
Dinucleotide (CA) repeat polymorphism studies
were carried out according to methods slightly modi-
fied from those of Weber and May (1989). The stan-
dard PCR contained 0.03 jg of genomic DNA and
0.06 Rg of each primer in a volume of 15 gl. Amplifi-
cation (27 cycles) was carried out in microtiter plates
(Stratagene SCS 96 thermal cycler) with denaturing
for 940C (1 min), 550C (2 min), 72"C (1 min). The
final extension was for 6 min at 720C. After amplifi-
cation, the products were separated on 6.5% denatur-
ing polyacrylamide gels (IBI STS-45). Markers used
for linkage of LGM1 to chromosome 5 are listed in
table 1.
Statistical Analysis
LGM1 was analyzed as an autosomal dominant
trait with age-dependent penetrance. The gene fre-
quency for LGM1 was fixed at 1/10,000. Two-point
Z values were calculated with the computer program
LIPED (Ott 1974). Allele frequencies for the RFLP
markers used were those published elsewhere (Kidd et
al. (1989) but did not deviate from those in our sample
population. Allele frequencies for the dinucleotide re-
peat markers were generated from a series of at least
110 unrelated individuals (table 1). To facilitate com-
puter analysis, the genotype results for the dinucleo-
tide repeat markers D5S119, DSS210, D5S207, and
IL-9 were recycled as suggested by Ott (1978), to mini-
mize the number of alleles while preserving the linkage
information. Support intervals about the estimate of
0 were calculated using the "one LOD score down"
method (Conneally et al. 1985). The analyses were
repeated using a low-risk penetrance for all unaffected
family members (i.e., an affecteds-only analysis). For
this analysis, genotype information was preserved on
all unaffected family members while eliminating the
phenotypic information regarding disease status, in
order to evaluate the contribution of known affecteds.
A genetic map for the markers D5S119, D5S207,
D5S210, IL-9, and D5S70 was not available. There-
fore, we attempted to generate a map based on the
available information within the family. Map genera-
tion via a full likelihood analysis on the intact pedigree
by the ILINK subprogram of the LINKAGE computer
package on a 4/370 Sun workstation was not feasible,
for computational reasons. Reducing the family to its
nuclear components to facilitate mapping efforts led
to the loss of a considerable amount of information
(e.g., for D5S210-D5S70 and D5S70-LGMD, the
peak Z values were reduced by 25% and 71 %, respec-
tively). Thus, multiple pairwise mapping techniques
(Morton and Collins 1989) were used to generate a
genetic map of this region.
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Markers with Allele Frequencies (for Microsatellite Repeat Markers) Used for Linkage of LGMD to
Chromosome S
Locus Marker Chromosomal Localization Fragment Sizea (% observed) Reference
DSS119 ........ Mfd6 5q31.1-31.1 202 bp (2)
200 bp(6)
198 bp (2) Weber et al., submitted
194bp (4)
192 bp (63)
190 bp (23) J
D5S207 ........ Mfd43 5q31.1-31.3 141 bp (32)
139 bp (52) Weber et al., submitted
137 bp(8)
135 bp(8)J
DSS210 ........ Mfdl22 5q31.1-31.3 230bp (5)
228 bp(3)




IL-9 5q22.3-31.3 139 bp (4)
137 bp(9)
133 bp (26) Polymeropoulos et al. 1991
131 bp (21)
129bp(9) J
DSS70........ pTP5E 5q33-q35 As published Farber et al. 1988
a Included in the analysis are only those that appeared within the pedigree. Other fragment sizes were observed on the screening of random
individuals but are not included in this table.
Results
LGM1 was excluded for 45 cM proximal to
D15S25 and for 40 cM distal to D15S25, the marker
most tightly linked to LGM2 (data not shown). These
data clearly exclude LGM1 from the LGM2 gene re-
gion. Linkage was established, however, for LGM1,
by a series of microsatellite repeat markers located on
chromosome 5q. The resulting two-point Z values are
shown in table 2. These markers all demonstrate link-
age to the LGM1 locus in this family. The peak Z
value is obtained with DSS210, which is linked to
LGMD with Z(O) = 10.81 at = .12. Figure 2 dem-
onstrates segregation of the D5S207/D5S210 haplo-
type in a subsection of family 39.
Table 2
Two-Point Z Values for Chromosome S Markers versus LGMD
Z AT 0 OF SUPPORT
Locus MARKER .001 .05 .10 .15 .20 .30 .40 o Z(O) INTERVALa
DSS119 ...... Mfd6 -12.81 -1.70 .01 .79 1.13 1.11 .55 .24 1.21 NA
D5S207 ...... Mfd43 -2.55 3.56 4.15 4.10 3.79 2.74 1.39 .11 4.16 .02-.25
D5S210 ...... Mfd122 -3.64 9.47 10.76 10.66 9.89 7.16 3.49 .12 10.81 .06-.21
IL-9 .25 9.61 10.30 9.94 9.07 6.48 3.49 .11 10.31 .04-.18
D5S70 ....... pTP5E -1.95 6.51 7.17 6.92 6.28 4.37 2.03 .11 7.19 .03-.21
a NA = not applicable.
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Figure 2 Portion of family 39 that demonstrates segregation of the D5S207/D5S210 haplotype with LGMD. Marker order is that
of the DSS210/D5S207 haplotype. These individuals are enclosed within the box in fig. 1. Results in brackets are inferred.
Results of the affecteds-only analysis are summa-
rized in table 3. Results for DSS210, D5S70, and IL-9
remained significant, although the peak Z values are
reduced. Comparison of the full-pedigree analysis
with the affecteds-only analysis gives a peak Z value
of 10.31 at 0 = .11, versus a peak Z value of 8.48
at = .06. These data indicate evidence for more
recombination within the full pedigree and suggest
that there are older unaffected individuals in the analy-
sis who carry the LGM1 chromosome 5 haplotype.
Peak Z values for the chromosome 5 marker-to-
marker linkage analysis are presented in table 4. In
order to define flanking markers for the LGM1 gene,
we attempted to generate a genetic map from the
markers D5S210, D5S70, and IL-9 by using multi-
ple pairwise analysis (Morton and Collins 1989).
Although we could confidently exclude the order
DSS210-IL-9-DSS70, the other two orders were of
Table 3
Two-Point Z Values for LGMD versus Markers in
Affected Family Members Only
MARKER Z(6)
DSS119.............. .23 .57
DSS207 .............. .09 2.38
D5S210 .............. .09 8.21
IL-9 .............. .06 8.48
DSS70 .............. .09 4.55
approximately equal likelihood. Additional informa-
tion with regard to the genetic map of this region is
necessary before a meaningful multipoint analysis of
LGM1 in this family can be performed.
Discussion
These studies demonstrate linkage of LGM1 to
chromosome 5q22.3-31.3. Genetic heterogeneity in
LGMD is already defined by the presence of both a
dominant and a recessive form of the disease. The
advantage of working with a single large pedigree is
evident, as difficulties with potential genetic heteroge-
Table 4
Chromosome S Marker-to-Marker Two-Point Z
Values
MARKERS 0 Z(6) Support Interval
DSS119/D5S207 ....... 13 5.16 .06-.22
D5S119/D5S210 ....... 15 6.40 .07-.23
D5S119/IL-9 ............ NA NA NA
D5S119/D5S70 ......... 30 .67 NA
D5S207/D5S210 ....... 00 24.73 .00-.03
D5S207/IL-9 ............ 13 6.62 .07-.22
DSS207/DSS70 ......... 02 11.62 .001-.09
DSS210/IL-9 ............ 15 10.13 .09-.21
D5S210/D5S70 ......... 03 22.40 .001-.04
IL-9/DSS70 .............. .11 7.15 .07-.21
NOTE.-NA = not applicable.
1215
1216 Speer et al.
neity are circumvented. The limitation of studying a
single large pedigree, however, is the inability to gen-
eralize from the significance of this one family to the
diagnostic entity as a whole. Family 39 is unusual
in its clinical presentation, because of the dysarthria.
Whether this is evidence of additional heterogeneity
within the autosomal dominant form is not known.
We are presently studying several other LGM1 fami-
lies to assess the extent of heterogeneity. Worthy of
additional note is a study by Morton (1959) which
suggested that there were two loci either of which,
when homozygous, could lead to the phenotype of
LGMD. If this proves to be the case, then genetic heter-
ogeneity will be demonstrated even within the reces-
sive form of LGMD.
With the linkage of LGM1 to chromosome 5, the
present study demonstrates locus heterogeneity for a
set of similar clinical entities of different inheritance
patterns. Clinically, family 39 and the recessive fami-
lies from the Isle of La Reunion are similar in that
affected individuals have elevated creatine kinase lev-
els, proximal weakness beginning in the hip and shoul-
der girdle, and a slowly progressive course. The pri-
mary difference, in affected individuals, between
family 39 and these recessive families is in the age at
onset. Affected individuals in the Isle of La Reunion
families generally have onset at age 8-15 years and are
usually ambulatory until age 30 years. Another large,
inbred, recessive, Amish family (Jackson and Strehler
1968) demonstrates a clinical presentation similar to
that in the Isle of La Reunion families, with juvenile
onset (average onset is at age 7 years). In contrast, the
mean age at onset in family 39 is 27.1 years. The
majority of family members are ambulatory for their
adult life.
The diagnostic complexities in LGM1 are under-
scored by the significant proportion (16% ) of individ-
uals in family 39 who are ofunknown diagnostic clas-
sification. Considering them to be of unknown
diagnostic status in the analysis could bias the result
by masking potential recombination events. There-
fore, all two-point analyses were also performed after
varying the clinical status of the individuals of uncer-
tain diagnosis. Studies were performed after assuming
that all uncertain individuals were either (1) affected,
(2) affected, but with allowance for 20% misdiagno-
sis, or (3) unaffected but at risk and therefore assigned
a probability of being affected that was based on age
at examination. Regardless of the clinical status as-
signed to these status-unknown individuals, all two-
point results for the markers DSS210, DSS70, and
IL-9 were significant, and they remained so even after
the Z criterion level of significance for multiple analy-
ses was increased as suggested by Goldin (1990).
These results indicate that the linkage ofLGM1 in this
family is robust, no matter what the clinical status.
The possibility of homology between chromosomes
15q and Sq has been raised (Donlon and Malcolm
1991). LGM2 and Marfan syndrome have been local-
ized to a small region of chromosome 1Sq, while
LGM1 and congenital contractural arachnodactyly
(Lee et al. 1991), which is phenotypically similar to
Marfan syndrome, have been localized to Sq. Al-
though these similarities may be purely coincidental,
they are intriguing nonetheless and warrant further
investigation.
A limitation of the present study is the inability,
because of the unavailability of a well-supported ge-
netic map, to define flanking markers tightly linked to
LGM1. Future efforts will be focused on assessing the
extent of heterogeneity within other autosomal domi-
nant LGMD families, as well as on producing a well-
supported genetic map from reference pedigrees, in
order to localize LGM1 on chromosome Sq more ac-
curately.
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